首页 | 本学科首页   官方微博 | 高级检索  
     

糖尿病治疗中多肽类药物新型缓控释给药制剂的研究进展
引用本文:宣吉明,程玉松,高静,钟延强. 糖尿病治疗中多肽类药物新型缓控释给药制剂的研究进展[J]. 药学实践杂志, 2012, 30(1): 14-18,37
作者姓名:宣吉明  程玉松  高静  钟延强
作者单位:1. 第二军医大学药学院药剂教研室,上海,200433
2. 南京军区联勤部卫生部上海药品器材供应站,上海,200052
摘    要:多肽类降血糖药物具有模拟正常人的生理性胰岛素分泌的功能,并且其降糖作用与患者血糖水平有关,很少发生低血糖事件。现就治疗糖尿病的多肽类药物新型缓控释制剂作一综述。

关 键 词:糖尿病治疗  多肽  缓控释给药
收稿时间:2011-05-22
修稿时间:2011-12-15

Developments of sustained and controlled release delivery systems of peptides in treatment of diabetes
XUAN Ji-ming,CHENG Yu-song,GAO Jing and ZHONG Yan-qiang. Developments of sustained and controlled release delivery systems of peptides in treatment of diabetes[J]. The Journal of Pharmaceutical Practice, 2012, 30(1): 14-18,37
Authors:XUAN Ji-ming  CHENG Yu-song  GAO Jing  ZHONG Yan-qiang
Affiliation:Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, China;Drugs and Instruments Supplying station in Nanjing,Department of health of Jiont logistics of Nanjing Military Region,Shanghai 200052,China;Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, China;Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
Abstract:Peptide analog of hypoglycemic drugs had a normal physiological function of insulin secretion. The hypoglycemic effect of peptide depended on blood glucose levels of patients, which induced very few incidents of hypoglycemia. Peptides of sustained and controlled release delivery systems in diabetes treatment were summed up in this paper.
Keywords:diabetes treatment  peptide  sustained and controlled release delivery systems
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《药学实践杂志》浏览原始摘要信息
点击此处可从《药学实践杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号